VIM Gene Variant Association to the Co-Occurrence of Livedoid Vasculopathy, Premature Canities, and Early-Onset Cataracts, and Preliminary Efficacy of Tofacitinib: A Case Report
Journal of Inflammation Research · 2026-05 · Volume 19 · 1-6
DOI: 10.2147/jir.s589526 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Inflammation Research, 2026-05. Verfasst von Zhujing Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic …. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China.
Zitieren
APA
Zhu, Z., & Qu, H. (2026). VIM Gene Variant Association to the Co-Occurrence of Livedoid Vasculopathy, Premature Canities, and Early-Onset Cataracts, and Preliminary Efficacy of Tofacitinib: A Case Report. Journal of Inflammation Research, Volume 19, 1-6. https://doi.org/10.2147/jir.s589526
Vancouver
Zhu Z, Qu H. VIM Gene Variant Association to the Co-Occurrence of Livedoid Vasculopathy, Premature Canities, and Early-Onset Cataracts, and Preliminary Efficacy of Tofacitinib: A Case Report. Journal of Inflammation Research. 2026;Volume 19:1-6. doi:10.2147/jir.s589526
BibTeX
@article{Zhu2026,
author = {Zhu, Zhujing and Qu, Huanru},
title = {VIM Gene Variant Association to the Co-Occurrence of Livedoid Vasculopathy, Premature Canities, and Early-Onset Cataracts, and Preliminary Efficacy of Tofacitinib: A Case Report},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--6},
doi = {10.2147/jir.s589526}
}
EUVIMED